Renibus Therapeutics
Southlake
About Renibus Therapeutics
Renibus Therapeutics is a clinical-stage biotech company transforming outcomes in cardiothoracic surgical patients. It has developed a portfolio of products that activate multiple cytoprotective pathways, including organ protection via preconditioning.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $214.7M
- Funding stage: Early Stage Venture
- Last round: Series B (Sep 2023)
- Website: renibus.com
- Phone: 682 285 1711
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/renibus-therapeutics-79932 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.